Multivariate regression analysis showed that plasma sF11R levels were independently associated with ANXA5 in the total population (model III: β = −0.366, p = 0.007; Table 4) and in poorly-controlled patients with HbA1c > 6.5% (model III: β = −0.425, p = 0.008; Table 4), but not in well-controlled patients with HbA1c ≤ 6.5%, after adjusting the model for multiple independent variables, such as gender, age, weight, hypertension, dyslipidemia, stroke, smoking, creatinine, total cholesterol, LDLc, HDLc, triglycerides, diabetes duration, and total NO (Table 4). Here, ANXA5 is linked to metabolic syndrome.